From Mayo Clinic to Waud Capital: What Dr. Edith Perez Sees in Private Equity Healthcare
Dr. Edith A. Perez’s career transition from Mayo Clinic Professor Emeritus to Chief Medical Officer of a Waud Capital Partners portfolio company signals a fundamental shift occurring across American healthcare. When physicians of her caliber—with over 300 published research articles and groundbreaking contributions to breast cancer treatment—choose private equity-backed platforms over traditional academic or corporate medicine roles, it reflects broader industry evolution that savvy healthcare leaders recognize and embrace.
Her appointment at Cornerstone Specialty Network represents more than individual career advancement. It demonstrates how private equity firms like Waud Capital Partners are attracting top medical talent by offering resources, scale, and operational support that academic institutions and hospital systems increasingly struggle to provide.
The Healthcare Transformation Attracts Elite Talent
Traditional healthcare career paths are changing as academic medical centers face budget pressures, hospital systems prioritize financial metrics over clinical innovation, and pharmaceutical companies restructure research operations. Elite physicians like Dr. Perez increasingly seek platforms that combine clinical excellence with operational efficiency and growth resources.
Dr. Perez’s career progression illustrates this evolution. After two decades at Mayo Clinic establishing herself as a leader in oncology research, she transitioned to Genentech as Vice President and Head of U.S. BioOncology Medical Affairs. She then joined Bolt Biotherapeutics as Chief Medical Officer before choosing Waud Capital’s Provider Network Holdings platform.
Each transition moved her closer to organizations that could provide the scale and resources needed to impact patient care across broad populations. Academic medicine offers research opportunities but limited operational reach. Pharmaceutical companies provide resources but narrow therapeutic focus. Private equity-backed healthcare platforms can offer both clinical scope and operational scale.
Waud Capital’s Clinical-First Approach
Reeve Waud’s success attracting medical talent stems from his healthcare-focused investment philosophy developed over 30 years and 480+ transactions. Unlike generalist private equity firms that prioritize financial engineering, Waud Capital Partners demonstrates deep understanding of clinical operations and patient care quality requirements.
The firm’s track record with Acadia Healthcare—which Waud founded in 2005 and built into a 260+ facility network before its 2011 IPO—demonstrates ability to scale healthcare platforms while maintaining clinical excellence. Waud’s continued role as Acadia’s Chairman signals long-term commitment beyond typical private equity hold periods.
This approach attracts physicians who understand that sustainable healthcare improvement requires both clinical expertise and operational excellence. Dr. Perez’s appointment reflects confidence that Waud Capital Partners can provide the platform needed to advance specialty care delivery at scale.
Technology and Scale Enable Clinical Innovation
Provider Network Holdings offers Dr. Perez something individual practices cannot: access to data and clinical insights across 1,500 specialty providers spanning multiple therapeutic areas. Her role involves “utilizing novel tools to optimize patient care by developing collaborative, retrospective, and prospective data generation and insights, across the network.”
This opportunity reflects broader healthcare trends toward data-driven care improvement and population health management that require scale and technological capabilities beyond individual practice capacity.
